| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 20 | |
| #2 | EPO (European Patent Office) | 19 | |
| #3 | WIPO (World Intellectual Property Organization) | 14 | |
| #4 | United States | 10 | |
| #5 | Australia | 9 | |
| #6 | Hong Kong | 5 | |
| #7 | China | 4 | |
| #8 | Israel | 3 | |
| #9 | Canada | 2 | |
| #10 | Mexico | 2 | |
| #11 | Norway | 2 | |
| #12 | New Zealand | 2 | |
| #13 | Poland | 2 | |
| #14 | Brazil | 1 | |
| #15 | Czechia | 1 | |
| #16 | Hungary | 1 | |
| #17 | Japan | 1 | |
| #18 | Republic of Korea | 1 | |
| #19 | Taiwan | 1 | |
| #20 | Ukraine | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines | |
| #4 | Measurement | |
| #5 | Organic fine chemistry | |
| #6 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Unspecified technologies | |
| #5 | Analysing materials | |
| #6 | Microorganisms | |
| #7 | Specific use of cosmetics | |
| #8 | Animal care |
| # | Name | Total Patents |
|---|---|---|
| #1 | Deghenghi Romano | 28 |
| #2 | Boutignon Francois | 25 |
| #3 | Larsen Finn | 13 |
| #4 | Millar Robert Peter | 9 |
| #5 | Maudsley Stuart Russell | 6 |
| #6 | Fisher Julian Robert Walker | 4 |
| #7 | Morley Timothy | 4 |
| #8 | Romano Deghenghi | 3 |
| #9 | Papotti Mauro | 2 |
| #10 | Maudsley Stuart Russel | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2008071984A1 | Administration of the gonadotropin-releasing hormone antagonist teverelix | |
| GB0712634D0 | New formulations | |
| GB0705057D0 | Agents, method and uses | |
| GB0625995D0 | Bigel composition | |
| GB0616111D0 | Agents, methods and uses | |
| GB0603295D0 | Methods and kits | |
| GB0520003D0 | Method for preparing a composition | |
| GB0422012D0 | Methods of treatment | |
| GB0406048D0 | Drug formulations | |
| GB0322921D0 | Methods of treatment | |
| WO2004009636A2 | Gnrh modulator | |
| AU2003248955A1 | Screening method | |
| WO2004010146A1 | Screening method and anti-tumor drug candidate obtained therefrom | |
| GB0310678D0 | Screening method and drug candidate obtained therefrom | |
| GB0308890D0 | Screening method | |
| GB0304726D0 | New Process | |
| GB0223254D0 | Methods of treatment | |
| GB0222541D0 | "Novel GnRH modulator" | |
| GB0221711D0 | Methods | |
| GB0221712D0 | Methods of treatment |